The expressions of GLI1 target genes, such as Forkhead Box M1 (FOXM1), B cell-specific Moloney murine leukemia virus integration site 1 (BMI1), and NANOG, were elevated in NSCLC patients [70, 71]. This evidence concerns the gene FOXM1 and non-small cell lung carcinoma.